Bastide Le Confort Medical SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0000035370
EUR
25.10
0.4 (1.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Bastide Le Confort Medical SA stock-summary
stock-summary
Bastide Le Confort Medical SA
Pharmaceuticals & Biotechnology
Bastide le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for elderly, sick or handicapped people, for healthcare professionals and individual clients. The Company’s product and services are divided into three divisions: home care equipment and services like wheelchairs, ergonomic pillows, anti-bedsore supports, self-diagnostic equipment and personal assistance products; perfusion and nutrition equipment and services like perfusion instruments, insulin pumps and syringe-drivers and respiratory assistance equipment and services like respirators, oxygen concentrators and oxygen tanks. In addition, the Company is involved in the rental and maintenance of medical equipment, such as insulin pumps, ventilators and nutrition check instruments. It operates through Societe S'Care Assistance, Bordo2 Medica, Medsoft, ATS Rhone Alpes SARL, tCM Pharma and Air+ Sante.
Company Coordinates stock-summary
Company Details
Centre d'activite Euro 2000, 12 avenue de la Dame CAISSARGUES None : 30132
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Guy Bastide
Chairman of the Board, Chief Executive Officer
Mr. Vincent Bastide
Deputy Chief Executive Officer, Director
Ms. Brigitte Bastide
Director
Ms. Dorothee Bravard
Director
Ms. Marie-Therese Swatek
Director
Mr. Claude Vincent
Director
Mr. Jean-Noel Cabanis
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 192 Million ()

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

4.82

stock-summary
Return on Equity

12.82%

stock-summary
Price to Book

2.67